Related Experiment Video
Updated: Aug 18, 2026

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
Published on: September 30, 2016
Planning the duration of accrual and follow-up for clinical trials
Abstract:
In clinical trials, the duration of accrual and follow-up are chosen to ensure an adequate power to detect a specified difference at a given level of significance, but appropriate choices for durations of accrual and follow-up are not unique. Methods of determining appropriate combinations for the accrual and follow-up periods are given and the unique cost effective choice of accrual and follow-up periods is presented. The accrual period can be substantially decreased by including a short follow-up period. The unique cost effective duration of follow-up depends on the ratio of the cost of accruing patients to the cost of following patients for end point determination.
Related Concept Videos
Clinical Trials
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview
Preclinical Development: Overview
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Bioavailability Study Design: Healthy Subjects Versus Patients
Clinically Relevant Drug Product Specifications: Methods of Establishment

